Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1990-3-2
|
pubmed:abstractText |
The effects of nebivolol, the racemic mixture of the SRRR and RSSS enantiomers, on beta-adrenoceptor-mediated cAMP accumulation in living cardiac cells were compared to those of beta-adrenoceptor antagonists. Serum-free cultivation of cardiac cells from ventricles of 2 to 3-day-old Wistar rats resulted in a population of contractile cardiac cells almost free of mesenchymal non-myocardial cells. Isoproterenol stimulated beta 1- as well as beta 2-adrenoceptor sites. Selective beta 1- and beta 2-receptor site occlusion, in the presence of an appropriate concentration of the selective beta 2-adrenoceptor antagonist, ICI 118-551, or the selective beta 1-adrenoceptor antagonist, CGP 20712-A, showed that the receptor population consisted of mostly the beta 1-adrenergic subtype. The latter could be specifically stimulated by noradrenaline. Nebivolol and d-nebivolol (SRRR) inhibited noradrenaline-induced cAMP accumulation with IC50 values of 22 and 15 nM, respectively. CGP 20712-A was 10 times more active and atenolol was 7 times less active than nebivolol. Both assays, beta-adrenoceptor binding and cAMP accumulation, evidenced beta-adrenoceptor antagonistic properties only for the d-enantiomer of nebivolol (SRRR). 1-Nebivolol (RSSS) showed no beta-adrenergic activity.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic beta-Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Benzopyrans,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclic AMP,
http://linkedlifedata.com/resource/pubmed/chemical/Ethanolamines,
http://linkedlifedata.com/resource/pubmed/chemical/Isoproterenol,
http://linkedlifedata.com/resource/pubmed/chemical/Norepinephrine,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Adrenergic, beta,
http://linkedlifedata.com/resource/pubmed/chemical/nebivolol
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0014-2999
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
5
|
pubmed:volume |
172
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
471-9
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2575531-Adrenergic beta-Antagonists,
pubmed-meshheading:2575531-Animals,
pubmed-meshheading:2575531-Benzopyrans,
pubmed-meshheading:2575531-Cells, Cultured,
pubmed-meshheading:2575531-Cyclic AMP,
pubmed-meshheading:2575531-Ethanolamines,
pubmed-meshheading:2575531-Isoproterenol,
pubmed-meshheading:2575531-Lung,
pubmed-meshheading:2575531-Myocardium,
pubmed-meshheading:2575531-Norepinephrine,
pubmed-meshheading:2575531-Rabbits,
pubmed-meshheading:2575531-Rats,
pubmed-meshheading:2575531-Receptors, Adrenergic, beta,
pubmed-meshheading:2575531-Stereoisomerism
|
pubmed:year |
1989
|
pubmed:articleTitle |
Beta-adrenoceptor-mediated cAMP accumulation in cardiac cells: effects of nebivolol.
|
pubmed:affiliation |
Department of Biochemical Pharmacology, Janssen Research Foundation, Beerse, Belgium.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|